Cancer
A new research report from the Inha University College of Medicine in South Korea discusses the recent advancements in delivery systems for transcription factors (TFs), which have opened new therapeutic opportunities in regenerative medicine, cancer therapy, and genetic disorders. The study highlights the challenges faced by effective TF delivery, including
Cancer
Scientists at the University of Texas Austin have made a significant breakthrough in cancer therapy with the development of a new generation of drug delivery systems. These systems, designed to respond to the unique conditions of the tumor microenvironment, have the potential to revolutionize the treatment of cancer. According to
Cancer
A study published online in the International Journal of Gynecological Cancer has shown that dostarlimab plus carboplatin-paclitaxel treatment is associated with improved survival and maintenance of quality of life for patients with advanced or recurrent endometrial cancer. The research, led by Dana M. Chase, M.D., from the David Geffen
Cancer
Researchers at Fudan University have made a significant discovery in the field of immunotherapy, utilizing a novel approach to target and eliminate gastrointestinal cancer (GIC) cells. The study, published in Cancer Immunology Research, employed a Sequentially Tumor-selected Antibody and Antigen Retrieval (STAR) system to isolate a nanobody that directs CAR
Cancer
Researchers at Zhejiang Chinese Medical University have developed virus-mimic nanoparticles that exhibit enhanced permeability, active targeting ability, and smart responsiveness, demonstrating improved cancer therapy efficacy and biocompatibility. These nanoparticles, inspired by viral structures, were designed to target tumor cells and release cancer-fighting agents. The study's findings suggest that
Cancer
Scientists from the Cancer Research UK Scotland Centre and the University of Edinburgh have made a groundbreaking discovery about the behavior of aggressive bowel cancer cells. According to their study, these cells can lose their identity and adapt to resemble skin or muscle cells, enabling them to spread more aggressively.
Cancer
A recent study by the Cancer Research UK Scotland Centre and the University of Edinburgh has found that bowel cancer cells can adapt to resemble skin and muscle cells, enabling them to spread more aggressively. This discovery holds promise for making current treatments more effective and halting the disease'
Cancer
Researchers from Fujian Cancer Hospital have made a groundbreaking discovery in the field of nanotechnology, where they have successfully combined two small molecule inhibitors to enhance the anti-tumor immunity of CD8+ T cells. This novel strategy involves the co-encapsulation of SHP099, an allosteric inhibitor for Src-homology domain-containing protein tyrosine phosphatase-2
Cancer
The ARC-20 study, a Phase 1/1b dose-escalation and expansion study, evaluated the efficacy and safety of casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor, in patients with clear cell renal cell carcinoma (ccRCC) who had progressed on prior immunotherapy. Among the efficacy-evaluable population of 24 patients, 46%
Cancer
New research on the CSMD1 gene has shed light on its potential association with moderate intellectual disability, anxiety disorder, and obsessive-compulsive personality traits. According to a study published in the International Journal of Molecular Sciences, the CSMD1 gene plays a crucial role in various biological processes, including complement activity, brain
Cancer
Patients with cancer suffering from comorbid symptoms of depression can benefit from a psychotherapeutic treatment specifically tailored to the exceptional context of acute or chronic cancer treatment, according to new research. The study, conducted by the University Hospital Tubingen in Tubingen, Germany, found that a modified group interpersonal psychotherapy (IPT)
Cancer
Research findings indicate that sleep disturbances can be a significant barrier to normal functioning after cancer treatment, and cognitive behavioral therapy for insomnia (CBT-I) has been shown to be effective in addressing these issues. However, few studies have examined the prevalence, severity, and attribution of adverse events (AEs) that occur
